Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Q4 FY25 Earnings Presentation
47 slides from Balaji Amines's earnings presentation, Jun 6, 2025
Slide 1: Exchange filing letter for Q4FY25 investor presentation
6th June, 2025 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (
Slide 2: Investor Presentation – June 2025
Investor Presentation – June 2025
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 4: Results Highlights
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 5: FY25: Financial Highlights
FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -14% -31% -25% 1,671 353 232 21% 19% 1,430 265 159 14% 11% FY24 FY25 FY24 FY25 FY24 FY25 FY24 FY25 Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Standalone
Slide 6: Q4FY25: Financial Highlights
Q4FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -15% -36% -44% 423 106 72 25% 361 19% 321 17% 17% 68 54 40 31 10% 11% Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Q4FY24 Q3FY25 Q4FY25 Revenue (Rs. Crore) EBITDA (
Slide 7: Q4 FY25 - Consolidated Performance Highlights
Q4 FY25 - Consolidated Performance Highlights Revenue from Operations for Q4FY25 stood at ₹ 361 crore, as compared to ₹ 321 crore in Q3FY25. Total volumes stood at 25,871 MT for Q4FY25 as against 24,107 MT in Q3FY25. For Q4FY25, • Amines volumes stood at 8,316 MT • Amines Derivatives volumes stood a
Slide 8: New Project Highlights (1/2)
New Project Highlights (1/2) • Solar Power plan : First phase of Solar power plant of 8 MW DC(6 MW AC) is commissioned in April 2025. This will reduce the power bills of all the plants substantially in line with our commitment of Carbon emission reduction under ESG declarations. • Electronic Grade D
Slide 9: New Projects Highlights (2/2)
New Projects Highlights (2/2) New Projects: • The company is proposing to set up a plant for manufacture of N-(N-Butyl) Thiophosphoric Triamide(NBPT) with a capacity of 2500 TPA which will be taken up next Financial Year. • All the above projects will be completed by using internal accruals. New exp
Slide 10: Expansion Plans
Expansion Plans EXECUTED ON SCHEDULE IN PROGRESS UNDER EXECUTION EXECUTED SOLAR POWER Methylamines Dimethyl Ether NMM & MIPA/DIPA PLANT OF 6 MW AC • Market Leader in Methylamines • Dimethyl Ether (DME) with a • N-Methyl Morpholine(NMM) : A • We have executed Solar production in India with installed
Slide 11: Standalone Statement of Profit & Loss
Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q4FY25 Q3FY25 Q-o-Q FY25 FY24 Y-o-Y Total Revenue 327 305 7% 1296 1359 -5% Raw Material 179 164 706 756 Employee expense 21 17 73 72 Other expenses 64 66 268 263 EBITDA 64 57 12% 249 267 -7% EBITDA Margin 20% 19% 19% 20% Depreciation 1
Slide 12: Standalone Balance Sheet Statement
Standalone Balance Sheet Statement ASSETS (Rs. Crs.) Mar-25 Mar-24 EQUITY AND LIABILITIES (Rs. Crs.) Mar-25 Mar-24 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 828 719 (a) Equity Share capital 6 6 (b) Capital work-in-progress 151 141 (b) Other equity 1,649 1,528 Sub Total (C) 1,655
Slide 13: Standalone Cashflow Statement
Standalone Cashflow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Mar-25 Mar-24 Profit before Tax 209 232 Adjustment for Non-Operating Items 28 21 Operating Profit before Working Capital Changes 237 253 Changes in Working Capital 27 10 Cash Generated from Operations 264 263 Le
Slide 14: Consolidated Statement of Profit & Loss
Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q4FY25 Q3FY25 Q-o-Q FY25 FY24 Y-o-Y Total Revenue 361 321 12% 1,430 1,671 -14% Raw Material 198 178 781 903 Employee expense 23 19 80 82 Other expenses 72 71 304 332 EBITDA 68 54 26% 265 353 -25% EBITDA Margin 19% 17% 19% 21% Depreci
Slide 15: Consolidated Balance Sheet Statement
Consolidated Balance Sheet Statement ASSETS (Rs. Crs.) Mar-25 Mar-24 EQUITY AND LIABILITIES (Rs. Crs.) Mar-25 Mar-24 (1) NON-CURRENT ASSETS EQUITY (a) Equity Share capital 6 6 (a) Property, plant & equipment 998 891 (b) Other equity 1,839 1,715 (b) Capital work-in-progress 234 203 Attributable to ow
Slide 16: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Mar-25 Mar-24 Profit before Tax 213 302 Adjustment for Non-Operating Items 31 30 Operating Profit before Working Capital Changes 244 332 Changes in Working Capital 53 65 Cash Generated from Operations 297 397
Slide 17: About Us
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 18: Amines Industry – Unique but Critical Industry with growth potential
Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally The consumable nature of demand and the is expected to reach $11.61 billion in 2030. oligopolistic nature of the industry, results in In India, the Amine industry is oligopolistic a st
Slide 19: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India
Balaji Amines Ltd – A Leading player in Aliphatic Amines in India State-of-the-art Forward integrated manufacturing suite of products Largest manufacturer of Aliphatic Amines in facilities fully equipped with latest DCS 40+ Product Downstream products added based on strength of amine manufacturing w
Slide 20: Our Products are supplied to India’s fast-growing Industries
Our Products are supplied to India’s fast-growing Industries Industry Wise - Revenue Breakup 3% 4% 3% 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others 19
Slide 21: Highly Experienced Management Team
Highly Experienced Management Team Mr. A. Prathap Reddy Mr. D. Ram Reddy Mr. N. Rajeshwar Reddy Mr. A. Srinivas Reddy Executive Chairman Managing Director Whole Time Director Whole Time Director & CFO • Civil Engineer by Education. • 38 years of experience across • Commerce Graduate • Post Graduate
Slide 22: Diversified Product Portfolio
Diversified Product Portfolio Particulars Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing • Amine Derivatives are used to make further consumption and applications in a salts and other complex chemical Intermediates and API’s • Relatively small and fast-growin
Slide 23: Clientele
Clientele Amines Amine Derivatives Specialty & Other Chemicals 22
Slide 24: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Target fast growing industries Value Added Products Cater to fast growing industries, namely, Focus towards high-value derivatives and pharmaceuticals, agro-chemicals, refineries, specialty chemicals with an aim to move up water treatment, r
Slide 25: Key Products (Current & Proposed) in Portfolio
Key Products (Current & Proposed) in Portfolio Product Existing Installed Capacity Proposed Capacity Total Capacity after Application Areas (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMAC 31,000
Slide 26: We are Global suppliers – a significant validation of our Capabilities
We are Global suppliers – a significant validation of our Capabilities • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatem
Slide 27: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities ISO Certificate Two Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP 02.05.2023 ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP
Slide 28: Awards & Certificates – A Testimony of our capabilities
Awards & Certificates – A Testimony of our capabilities Product Innovator of Distinguished Excellent CSR in Water Mahatma Award for “Company of the Year” in International Tourism & the Year in Chemicals Contribution in the Conservation Sustainable and Responsible Chemicals at FICCI Chemicals Hospita
Slide 29: Awards & Recognition - A Testimony of our capabilities
Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre
Slide 30: We are Growing…Sustainably and Consistently
We are Growing…Sustainably and Consistently India Ratings Affirms Balaji Amines’ Bank Facilities at ‘IND AA’ “Latest Rating is Non- fund based Facilities INR 1500 Million IND A1+ ; Fund Based Working Capital Facilities INR 1450 Million IND AA / Stable / IND A1+ • Largest manufacturer of aliphatic am
Slide 31: High entry barrier Business – Paving way for Sustainable growth
High entry barrier Business – Paving way for Sustainable growth Complex Niche product High fixed costs, R&D focus to Continuous Hazardous nature manufacturing offering with high with fixed asset introduce new process ensures of the Process process requiring lead time in turns hovering in products fo
Slide 32: Well positioned Business Model aimed at Sustainable growth
Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty chemicals will materialize into higher 01 Solvents account for 80%-90% of the mass utilised in a typical pharmaceutical chemical 05 rev
Slide 33: Greenfield Project to fuel growth and add Revenue Visibility
Greenfield Project to fuel growth and add Revenue Visibility Strategically Project Accorded Product Profile Balaji Specialty Located Plant Mega Project Status Chemicals Environmental In Phase-1 of Greenfield Electronic Grade DMC Existing Maharashtra’s Energy and Labour clearance received for Project
Slide 34: Greenfield Project to fuel growth and add Revenue Visibility
Greenfield Project to fuel growth and add Revenue Visibility New Products = First Mover High Demand for Products Solar Power Plant advantage Significant opportunity The demand of Methylamines has The 20 MW Greenfield Solar Power Plant exists to introduce new increased in India. High demand is progre
Slide 35: About Balaji Speciality Chemicals
About Balaji Speciality Chemicals 01 02 03 Balaji Speciality Chemicals Limited (BSCL) is BAL owns 55% in subsidiary Balaji Speciality Received Mega project status for the Project from Manufacturing products such as Ethylene Diamine Chemicals Pvt. Ltd which is strategically located at Maharashtra Sta
Slide 36: R&D led Investments to provide significant early mover advantage
R&D led Investments to provide significant early mover advantage New Products Optimization Integration Identification of new products Continuous efforts to optimize Backward and forward integration and development of latest utilization of energy, utilities & raw of products to improve value chain pr
Slide 37: About Balaji Sarovar Premiere Hotel
About Balaji Sarovar Premiere Hotel • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu
Slide 38: Balaji Sarovar Premiere – FY25 Operating Matrix
Balaji Sarovar Premiere – FY25 Operating Matrix Constitutes Rs 3,320 Lakhs 5,001 129 Rooms 2.56% of from Hotel Division Rs. ADR Total Revenue Business 71% Rs. 3,560 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ADR : Average Daily Rate RevPAR: Revenue per Available Room 37
Slide 39: Financial Performance
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 40: Consolidated Performance Highlights
Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 1,430 379 353 244 232 265 159 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31
Slide 41: Strong Core ROCE Profile
Strong Core ROCE Profile Particulars (Rs. Crs.) FY25 FY24 ▪ During the year the following plants have been commissioned Consolidated Debt 11 20 1) Methylamines Plant 2) N-Butylamine Plant – Unit IV Consolidated Networth 2018 1893 3) Rooftop Solar Power Plants at various units Total Capital Employed
Slide 42: Consistent Dividend Payout
Consistent Dividend Payout 550% 550% 500% 300% 200% 160% FY20 FY21 FY22 FY23 FY24 FY25 Particulars (Rs. per share) FY20 FY21 FY22 FY23 FY24 FY25 Consolidated Book Value 206 281 406 524 584 623 Consolidated EPS 32 74 114 100 63 49 Dividend 3.20 4.00 6.00 10.00 11.00 11.00 41
Slide 43: Growth Prospects
Results Highlights About Us Financial Performance Moving towards Growth Prospects
Slide 44: Balaji Amines Ltd - Progressing steadily
Balaji Amines Ltd - Progressing steadily 1 2 3 4 5 Unit 4: Increased capacity Unit 4 : utilization & capacity Improvements at Greenfield projects of Greenfield Capex Phase - 2 & 3 additions of Phase - 1 Subsidiary Plant Subsidiary Plant capex Capex for Phase 2 & 3 of Expansion and Investments to be
Slide 45: ESG & CSR Initiatives
ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay University, Solapur dt. 10.12.2024 Penur,Mohol, Solapur dt 07.06.2024 Gotewadi, Mohol, Solapur dt.09.10.2024 Constructed
Slide 46: ESG & CSR Initiatives
ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Construction of Toilet Block at Indira Kale Prashala, Distributed Sanitary Napkin Incinerator and Vending Bhimgal, Nizamabad Jalkotwadi Machine at Vishwabhushan Vidyalay, Solapur dt. 04.01.2025 dt. 25.03.2025 dt.30.09.2024 Di
Slide 47: Thank You
For further information, please contact: Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Bhavya